(Q37755833)

22 August 2017

1 reference

title

Ibuprofen-induced hypersensitivity syndrome (English)

1 reference

22 August 2017

Radu M Nanau

1

1 reference

22 August 2017

Manuela G Neuman

series ordinal

2

1 reference

22 August 2017

publication date

25 February 2010

1 reference

22 August 2017

published in

Translational Research

1 reference

22 August 2017

volume

155

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

275-293

1 reference

Stereoselective and substrate-dependent inhibition of hepatic mitochondrial β-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Metabolic chiral inversion of ibuprofen in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen-induced liver mitochondrial permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Comparative bioavailability of three ibuprofen formulations in healthy human volunteers

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Fatality after deliberate ingestion of sustained-release ibuprofen: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

A double-blind, placebo controlled, cross-over comparison of the analgesic effect of ibuprofen 400 mg and 800 mg on laser-induced pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen disposition in obese individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Absorption kinetics of rectally and orally administered ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Acute non-oliguric kidney failure and cholestatic hepatitis induced by ibuprofen and acetaminophen: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Developmental aspects of human hepatic drug glucuronidation in young children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen-associated renal impairment in a large general internal medicine practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Incidence of drug-induced hepatic injuries: a French population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Hepatotoxicity associated with non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Hepatocellular damage from non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Stereoselective disposition of ibuprofen in patients with compromised renal haemodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen overdose: 126 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Serious toxicity in a young child due to ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Severe metabolic acidosis complicating massive ibuprofen overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Massive ibuprofen ingestion with survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Antiepileptic drug-induced hypersensitivity syndrome reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Apoptosis in ibuprofen-induced Stevens-Johnson syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Human leukocyte antigens and drug hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Delayed drug hypersensitivity reactions - new concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Comparative cytotoxicity of non-steroidal anti-inflammatory drugs in primary cultures of rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

The pathophysiology of tumor necrosis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Differential effect of cyclooxygenase metabolites on proinflammatory cytokine release by Kupffer cells after liver ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

A study of the relative hepatotoxicity in vitro of the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and butibufen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

The Food and Drug Administration algorithm. Special workshop--regulatory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Fatty liver and pleural effusion with ibuprofen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Lymphopenia and hepatic toxicity with ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Subfulminant hepatitis requiring liver transplantation following ibuprofen overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Acute vanishing bile duct syndrome after ibuprofen therapy in a child.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Influence of ibuprofen on drug-metabolizing enzymes in rat liver in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Hepatocellular proliferation in ibuprofen-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Stevens-Johnson Syndrome and cholestatic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Toxic shock syndrome or toxic epidermal necrolysis? Case reports showing clinical similarity and histologic separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

A marker for Stevens-Johnson syndrome ...: ethnicity matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Diagnosis of drug allergy by the lymphocyte stimulation test with the MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

In vitro study of matrix surface properties of porous granulated calcium phosphate ceramic materials made in Russia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Ibuprofen augments bilirubin toxicity in rat cortical neuronal culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Evaluation of the potential role of cytokines in toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

The effect of colestipol and cholestyramine on ibuprofen bioavailability in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

Enhanced chiral inversion of R-ibuprofen in liver from rats treated with clofibric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.01.005

10.1016/J.TRSL.2010.01.005

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference